Robust Omics-Algorithms based approach: Development of personalized Molecularly targeted therapy for Advanced cancer Patients

NIAID Data Ecosystem2026-03-10 收录

癌症精准医疗

药物反应预测

数据链接：

https://www.ncbi.nlm.nih.gov/bioproject/PRJNA484034 数据链接链接失效反馈

官方服务：

资源简介：

Matched WXS and RNA-Seq to investigate drug-response of metastatic triple-negative breast cancer patients

创建时间：

2018-08-01

Multi-omics and Machine Learning Accurately Predicts Clinical Response to Adalimumab and Etanercept Therapy in Patients with Rheumatoid Arthritis [Methylation array]. Multi-omics and Machine Learning Accurately Predicts Clinical Response to Adalimumab and Etanercept Therapy in Patients with Rheumatoid Arthritis [Methylation array]

药物反应预测

类风湿关节炎精准医疗

Objectives: To predict response prior to anti-TNF treatment and comprehensively understand the mechanism how patients respond differently to anti-TNF treatment in rheumatoid arthritis (RA). Methods: G

NIAID Data Ecosystem50

Additional file 7: of A systematic analysis of genomics-based modeling approaches for prediction of drug response to cytotoxic chemotherapies

基因组学

药物反应预测

MAD for SVRLN models reported in Results section A. and B. (XLSX 18 kb)

DataCite Commons2020-08-27 更新40

Forest plots of association between TPMT polymorphisms and AZA-induced overall ADRs (A), bone marrow toxicity (B), hepatotoxicity (C) and gastric intolerance (D).

药物基因组学

药物反应预测

Total: total number of patients with or without ADRs. Events: number of patients with one or more mutant TPMT alleles (TPMT*3A, TPMT*3B and TPMT*3C) within the ADRs or no ADRs group.

NIAID Data Ecosystem20

Additional file 22: of A systematic analysis of genomics-based modeling approaches for prediction of drug response to cytotoxic chemotherapies

药物反应预测

基因组学

This file includes the values of the Spearman correlation for NLSVR models corresponding to Figs. 3, 4, and 5. (XLSX 67 kb)

DataCite Commons2020-08-27 更新40

Table_2_A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma.xlsx

癌症精准医疗

治疗反应预测

Clear cell renal cell carcinoma (ccRCC) is a prevalent urinary malignancy. Despite the recent development of better diagnostic tools and therapy, the five-year survival rate for individuals with advan

NIAID Data Ecosystem30

Robust Omics-Algorithms based approach: Development of personalized Molecularly targeted therapy for Advanced cancer Patients

资源简介：

相关数据集